Cephalexin is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. It is widely indicated for treating various bacterial infections,… Read more
![Chemical structure of (6R,7R)-7-((Ethoxycarbonyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F72820-16-7-6R7R-7-Ethoxycarbonylamino-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (6R,7R)-7-((R)-2-((tert-Butoxycarbonyl)amino)-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6R7R-7-R-2-tert-Butoxycarbonylamino-2-phenylacetamido-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-3-ene-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-[(2r)-2-phenylacetic acid] Carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6R7R-7-2R-2-Amino-2-phenylacetylamino-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-2r-2-phenylacetic-acid-Carboxamide.png&w=3840&q=75)



![Chemical structure of 2-[N-(D-Phenylglycine-d5)]crotonic Acid Ethyl Ester Potassium Salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-N-D-Phenylglycine-d5crotonic-Acid-Ethyl-Ester-Potassium-Salt.png&w=3840&q=75)
![Chemical structure of 7-(2-Amino-2-(4-chlorophenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7-2-Amino-2-4-chlorophenylacetamido-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic-Acid.png&w=3840&q=75)



































Cephalexin is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. It is widely indicated for treating various bacterial infections, including those of the respiratory tract, urinary tract, skin, and soft tissues. Laboratories rely on high-quality reference standards of the Cephalexin active pharmaceutical ingredient, alongside its related impurities and metabolites, for comprehensive quality control, method validation, and regulatory compliance. Impurity profiling is essential for identifying process-related compounds and degradation products to ensure therapeutic safety and efficacy. Furthermore, stable isotope labelled compounds are indispensable as internal standards in mass spectrometry-based bioanalytical assays, such as LC-MS/MS, because they compensate for matrix effects and ionization variability to provide superior accuracy in pharmacokinetic and bioequivalence studies. These well-characterized analytical materials support consistent testing and precise quantification throughout the drug development and manufacturing lifecycle.